← Leaderboards
Matthew McMillin
Olin Teague Veterans Center
$0
Attributed
$0
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $0 · FY2017–22$1$1$1$0$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
VA$0 · 1
By mechanism
IK2$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Acute”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$51,003,204
- Julie Ake · National Institute Of Allergy And Infectious Diseases$41,692,120
- Xinhua Li · Nano Terra, Inc.$29,991,620
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$29,269,420
- Evan Z Macosko · Broad Institute, Inc.$27,107,011
Research focus
AcuteComorbidityAcute Liver FailureAcute Liver InjuryAcetaminophenAlcohol AbuseAlcohol HepatotoxicityApoptosisAzoxymethaneBile DuctBiliaryCell CommunicationCell Culture TechniquesCell CycleCell PhysiologyCellsCessation Of LifeCholestasisChronicChronic Liver DiseaseCirrhosisClassificationClinical TrialsDrug Abuse
Grant awards (6)
Pathogenic role of thrombospondin-1 in acute and chronic liver failure$0
IK2 · FY2022 · VA · contact PI
Pathogenic role of thrombospondin-1 in acute and chronic liver failure$0
IK2 · FY2021 · VA · contact PI
Pathogenic role of thrombospondin-1 in acute and chronic liver failure$0
IK2 · FY2020 · VA · contact PI
Pathogenic role of thrombospondin-1 in acute and chronic liver failure$0
IK2 · FY2019 · VA · contact PI
Pathogenic role of thrombospondin-1 in acute and chronic liver failure$0
IK2 · FY2018 · VA · contact PI
Pathogenic role of thrombospondin-1 in acute and chronic liver failure$0
IK2 · FY2017 · VA · contact PI